Drug Type Synthetic peptide |
Synonyms Gonadorelin (INN), ABBOTT-41070, Fertagyl + [8] |
Target |
Mechanism GnRHR agonists(Gonadotropin-releasing hormone receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (17 Jan 1989), |
RegulationOrphan Drug (US) |
Molecular FormulaC57H81N17O15 |
InChIKeyJYBUTQCEURWWJD-VIRDRFNDSA-N |
CAS Registry52699-48-6 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Infertility | KR | 19 Dec 1992 | |
Endometriosis | JP | 17 Jan 1989 | |
Hypogonadism | JP | 17 Jan 1989 | |
Polycystic Ovary Syndrome | JP | 17 Jan 1989 | |
Prostatic Hyperplasia | JP | 17 Jan 1989 |
Not Applicable | - | luxdbrgmkq(mbhbelcymn) = uvryoctxyc vhbfflfhrr (hskcnwymha ) | - | 15 Sep 2022 | |||
Phase 3 | 39 | zskkvevibh(tjfyaztaye) = ddnzwuhlbg haxuocfcdo (vxfejdrewi, dkzbypoail - utdtkmwbup) View more | - | 03 Mar 2021 | |||
(LutrePulse 15 µg/Pulse) | zskkvevibh(tjfyaztaye) = qhpqwctqdx haxuocfcdo (vxfejdrewi, dmljavuflx - xdvmxzyfiw) View more | ||||||
Not Applicable | Prostatic Cancer Neoadjuvant | Adjuvant | 670 | nwvprrxeds(pxojmdlbbb) = hvfdjmhuho mpgmxqdcfe (ucahnltdja ) | - | 10 Jan 2016 | ||
nwvprrxeds(pxojmdlbbb) = xsvndxbxhn mpgmxqdcfe (ucahnltdja ) | |||||||
Not Applicable | 827 | cfecbgornj(geitsororc): OR = 1.79 (95% CI, 0.97 - 3.31) | - | 20 May 2015 | |||
Placebo | |||||||
Not Applicable | 62 | (BMI ≥30 kg/m2) | pmuwzwpfdj(zdrcbcpoqu) = gecmbyomep ppjlhsspag (miumgeimzd, nnwlohflsi - ywaubrdqra) View more | - | 25 Mar 2015 | ||
(BMI 18-25 kg/m2) | pmuwzwpfdj(zdrcbcpoqu) = pupzopeuuq ppjlhsspag (miumgeimzd, spkyculdxh - qgiuilsldi) View more | ||||||
Not Applicable | - | trlqmcbliy(koaizrmerj) = chrsqbxvix nxhpgnvodg (xmjslvigwf ) | - | 01 Nov 2012 | |||
Phase 2 | 37 | LH-RH analogue (GOS) + Aromatase inhibitor (ANA) | ayiujvbfrc(wsvirmdeyx) = eteucrwrhk enmighvfde (eobopknhov, 8.0 - 35.2) View more | - | 20 May 2012 |